Noncontiguous local recurrence of posterior uveal melanoma after cobalt 60 episcleral plaque therapy
J. S. Duker, J. J. Augsburger and J. A. Shields
Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pa 19107.
Four patients with posterior uveal melanomas treated by cobalt 60
episcleral plaque therapy developed the intraocular recurrence of choroidal
melanoma at a site distant from and noncontiguous to their original
lesions. Three of the four patients died of metastatic melanoma. The
proportion of eyes with posterior uveal melanoma treated with cobalt 60
brachytherapy who subsequently develop this type of local recurrence
appears to be low (0.68%).
